Tag Archives: #FDA #COVID19 #EUA #BloodPlasma

FDA Credibility on the Line

Posted on August 24, 2020 by Mark Senak

In normal times, when there is no pandemic threatening our lives and livelihoods, it is essential for FDA to maintain the traditional “gold standard” in relation to the decision-making process for the approval of new treatments. That standard is even … Continue reading →

Posted in FDA Image, FDA Policy | Tagged | Comments Off on FDA Credibility on the Line